Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Cadila Healthcare

Sector: Healthcare | Industry: Drugs & Pharma
R 228.55 -1.90  | -0.82% -35.67% 13.88 23,479.54
NSE Price: Nov 13, 12:44 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 13, 12:44 228.55 -1.90 -0.82% 231.85 230.45 591,166 227.10 - 232.55
BSE Nov 13, 12:55 227.50 -2.75 -1.19% 230.00 230.25 50,382 225.65 - 232.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 2,179,355 P/B: 2.19 NSE Code: CADILAHC
52-Week Range: R 206.50 - 375.40 Dividend Yield: 1.53% BSE Code: 532321
TTM EPS: R 16.53 Book Value: R 104.53 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Cadila Healthcare -33.86 0.15 0.04 -35.87 -15.37 -6.74 11.68
S&P BSE Mid Cap -4.30 7.21 8.08 -1.13 5.83 7.93 8.59
S&P BSE Healthcare -5.73 8.01 3.41 -10.61 -5.34 -2.65 10.93
Company's return has been calculated on basis of NSE's price.
As on Nov 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.13 11.78 12.75
Net Profit 5.96 -1.22 17.23
EPS 4.11 -1.49 18.13
Book Value 18.78 22.15 24.74
Average
Operating Margin 24.11 23.52 23.49
Net Margin 13.85 14.63 15.53
Return on Networth 19.36 21.68 26.90
Return on Investment 15.88 16.88 20.49
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.34 20.82 -6.34
Operating Profit -21.96 -12.29 -21.96
Net Profit -34.31 -29.92 -34.31
EPS -34.02 -34.07 -34.02
TTM
Revenue 4.58 9.16 4.58
Operating Profit -2.89 -9.59 -2.89
Net Profit -7.26 -17.12 -7.26
EPS -8.49 -19.37 -8.49
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Cadila Healthcare 23,479.54 13,768.20 1,717.40 12.36 19.36 2.19 13.88
Lupin 33,074.54 17,689.22 318.63 1.77 4.55 2.43 105.40
Piramal Enterprises 36,195.05 14,278.56 1,708.87 11.71 4.28 1.36 17.52
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 04, 2019 Zydus Family Trust  Buy Market 17,500 230.25 40.29
Sep 04, 2019 Zydus Family Trust  Buy Market 250,723 230.25 577.29
Sep 03, 2019 Zydus Family Trust  Buy Market 17,420 228.95 39.88
Sep 03, 2019 Zydus Family Trust  Buy Market 234,428 228.95 536.72
Aug 30, 2019 Zydus Family Trust  Buy Market 7,427 225.25 16.73
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Kotak Mahindra Mutual Fund 1.911 1.905 1.078 0.856 0.847
Franklin Templeton Mutual Fund 1.573 1.636 1.568 1.553 1.549
UTI Mutual Fund 1.015 1.016 0.736 0.738 0.633
Nippon India Mutual Fund 0.715 0.687 0.594 0.435 0.435
ICICI Prudential Mutual Fund 0.635 0.614 0.355 0.386 0.383
Aditya Birla Sun Life Mutual Fund 0.404 0.266 0.141 0.164 0.087
IDFC Mutual Fund 0.401 0.483 0.347 0.508 0.324
DSP Mutual Fund 0.122 0.445 0.020 0.134 0.211
SBI Mutual Fund 0.118 0.118 0.182 0.177 0.235
PPFAS Mutual Fund 0.112 0.080 - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Cadila Healthcare Ltd.

Address: Zydus Corporate Park, Scheme No.63, Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat - 382481 | Phone: 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20 | Fax: 079- 26862365

Email: [email protected]

Website: www.zyduscadila.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009, 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I), Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road, Navrangpura

Essential checks
Altman Z-Score
2.85
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
13.93
5-Years Price to Book
2.20
Earnings Yield
EBIT / Enterprise value
8.02%
PEG
Price / Earnings to growth ratio
0.97
Related Stocks
  Current Price   Chng %
Abbott India R11,755.00 +0.48%
Alkem Laboratories R2,070.00 +4.97%
Aurobindo Pharma R440.25 +0.58%
Bayer CropScience R3,400.65 +0.06%
Biocon R259.50 -1.52%
Glaxosmithkline Pharma R1,601.80 -1.12%
Lupin R731.90 -0.52%
Pfizer R4,006.30 +0.28%
Piramal Enterprises R1,822.25 +2.31%
Torrent Pharmaceuticals R1,783.00 -1.13%
As on Nov 13, 12:44